May 5, 2022
The University of Cincinnati's LaTrice Montgomery was a guest on the Cannabis Man podcast to discuss the current state of cannabis research.
May 2, 2022
The University of Cincinnati's Alice Tang was featured in a Healio article discussing recently published research that administering an immunotherapy drug prior to surgery did not increase risks for patients with advanced oral cavity cancer.
April 29, 2022
The University of Cincinnati's Jill Boone was featured in a Local 12 story on the impact of staffing issues at local pharmacies.
April 26, 2022
The University of Cincinnati's Hyacinth I. Hyacinth was featured in a Spectrum News story about his research into biological factors that contribute to racial health disparities in patients with dementia.
April 20, 2022
Consumer Affairs and Healthing Canada recently featured research from the University of Cincinnati showing patients seeking treatment for depression who have lower income and education and those who are members of minority populations tend to have worse treatment outcomes even when receiving equal access to treatment.
April 19, 2022
The University of Cincinnati James L. Winkle College of Pharmacy, UC Medical Center and Walgreens are launching CincyUp, a first-of-its-kind visiting Advanced Pharmacy Practice Experience (APPE) pilot program for underrepresented pharmacy students.
April 18, 2022
Yahoo! News featured University of Cincinnati research into the use of Optune devices that provide electrical field treatment to the brain as a treatment for glioblastomas.
April 15, 2022
University of Cincinnati researchers Jeffrey Mills and Jeffrey Strawn have collaborated on a new research study showing socioeconomic factors affect outcomes for patients being treated for depression even when receiving equal access to care.
April 12, 2022
The University of Cincinnati's Kate Chard was featured in a Reuters Health article examining a study of video tablet telehealth mental health services for veterans.
April 12, 2022
The University of Cincinnati's Kyle Wang, MD, is the site principal investigator for the Trident trial, studying the effectiveness of earlier electrical treatment through Optune devices to treat glioblastomas.